$20.49
0.69% today
Nasdaq, Dec 04, 10:00 pm CET
ISIN
US8292141053
Symbol
SLP

Simulations Plus, Inc. Stock price

$20.35
+3.41 20.13% 1M
-7.69 27.43% 6M
-7.54 27.03% YTD
-10.98 35.05% 1Y
-19.72 49.21% 3Y
-35.53 63.58% 5Y
+11.45 128.65% 10Y
+19.46 2,192.96% 20Y
Nasdaq, Closing price Wed, Dec 03 2025
+0.82 4.20%

Key metrics

Basic
Market capitalization
$409.9m
Enterprise Value
$381.5m
Net debt
positive
Cash
$28.5m
Shares outstanding
20.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.1 | 5.2
EV/Sales
4.8 | 4.8
EV/FCF
36.2
P/B
3.3
Dividends
DPS
$0.24
Yield 1Y | 5Y
1.2% | 0.5%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
49.0% | 45.6%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$80.4m | $79.6m
EBITDA
$13.8m | $20.2m
EBIT
$4.7m | $-47.4m
Net Income
$-63.2m | $-65.5m
Free Cash Flow
$10.6m
Growth (TTM | estimate)
Revenue
20.0% | 13.7%
EBITDA
19.6% | 71.2%
EBIT
-33.1% | -873.4%
Net Income
-755.5% | -758.2%
Free Cash Flow
3.4%
Margin (TTM | estimate)
Gross
53.8%
EBITDA
17.1% | 25.4%
EBIT
5.8%
Net
-78.6% | -82.3%
Free Cash Flow
13.1%
Financial Health
Equity Ratio
92.8%
Return on Equity
5.5%
ROCE
3.8%
ROIC
4.3%
Debt/Equity
0.0
More
EPS
$-3.1
FCF per Share
$0.5
Short interest
11.0%
Employees
245
Rev per Employee
$290.0k
Show more

Is Simulations Plus, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

Simulations Plus, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Simulations Plus, Inc. forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Simulations Plus, Inc. forecast:

Buy
64%
Hold
36%

Financial data from Simulations Plus, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '25
+/-
%
80 80
20% 20%
100%
- Direct Costs 37 37
102% 102%
46%
43 43
11% 11%
54%
- Selling and Administrative Expenses 31 31
14% 14%
39%
- Research and Development Expense 7.13 7.13
45% 45%
9%
14 14
20% 20%
17%
- Depreciation and Amortization 9.06 9.06
101% 101%
11%
EBIT (Operating Income) EBIT 4.68 4.68
33% 33%
6%
Net Profit -63 -63
755% 755%
-79%

In millions USD.

Don't miss a Thing! We will send you all news about Simulations Plus, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Simulations Plus, Inc. Stock News

Positive
The Motley Fool
about 4 hours ago
Shares of Simulations Plus had gained more than 20% as of midday Thursday. The company reported mixed results, but its guidance calls for revenue and earnings growth in fiscal 2026 despite a difficult environment.
Neutral
Seeking Alpha
2 days ago
Simulations Plus is a specialized in silico software-and-services platform. They help with model-informed, non-animal drug development. SLP's services help across discovery, development, and clinical operations. Software remains their main economic driver with higher margins. Services are growing faster and gradually increasing their share of total revenues but have lower margins.
Positive
The Motley Fool
2 days ago
Its full-year fiscal 2025 featured a double-digit revenue increase. As for the fourth quarter, its performance was mixed.
More Simulations Plus, Inc. News

Company Profile

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered Lancaster, CA.

Head office United States
CEO Mr. O'Connor
Employees 245
Founded 1996
Website www.simulations-plus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today